FREELINE THERAPEUTICS HLDGS
CUSIP 35655L107
Freeline Therapeutics Hldgs has 16 institutional holders in Filings Flow’s 13F database, together reporting 37.87M shares worth $19M as of Q4 2022. The largest reported holders are Syncona Portfolio Ltd, Eventide Asset Management, LLC, and Chi Advisors LLC.
Institutional Holders
16
Q4 2022
Reported Value
$19M
Ticker
unmapped
private placement or foreign
Quarters Tracked
3
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| CHI Advisors LLC$252M AUM | 0.57% | $2M | 4.73M | Q1 2023OLDER |
| Tetragon Partners GP Ltd$515M AUM | 0.24% | $2M | 4.00M | Q1 2023OLDER |
| EVENTIDE ASSET MANAGEMENT, LLC$6.0B AUM | 0.04% | $2M | 4.70M | Q1 2023OLDER |
| Odey Asset Management Group Ltd$381M AUM | 0.00% | $13,710 | 30.1K | Q1 2023OLDER |
| Aspire Private Capital, LLC$443M AUM | 0.00% | $546 | 1.2K | Q1 2023OLDER |
| RENAISSANCE TECHNOLOGIES LLC$63.9B AUM | 0.00% | $105 | 230.6K | Q1 2023OLDER |
| UBS Group AG$666.3B AUM | 0.00% | $227,500 | 500.0K | Q1 2023OLDER |
| TWO SIGMA INVESTMENTS, LP$123.9B AUM | 0.00% | $19,569 | 43.0K | Q1 2023OLDER |
| MILLENNIUM MANAGEMENT LLC$240.3B AUM | 0.00% | $75 | 162.2K | Q1 2023OLDER |
| CITADEL ADVISORS LLC$618.5B AUM | 0.00% | $53,726 | 116.8K | Q1 2023OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.